Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML)

Imatinib (Gleevec; STI-571) is a tyrosine-kinase inhibitor (TKI) used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most common adverse effects with imatinib include s...

Descripción completa

Detalles Bibliográficos
Autores principales: El Jurdi, Najla, Bankoff, Mark, Klein, Andreas, Saif, Muhammad W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
General Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963232/
https://www.ncbi.nlm.nih.gov/pubmed/27489753
http://dx.doi.org/10.7759/cureus.660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963232/
https://www.ncbi.nlm.nih.gov/pubmed/27489753
http://dx.doi.org/10.7759/cureus.660

Ejemplares similares